Research Article

Low Levels of CD36 in Peripheral Blood Monocytes in Subclinical Atherosclerosis in Rheumatoid Arthritis: A Cross-Sectional Study in a Mexican Population

Table 1

Characteristics and comparison of RA subgroups with and without increased cIMT.

VariableStudy groups
cIMT ≤ 0.6 mm
cIMT > 0.6 mm

Age, years 0.14
RA characteristics
Disease duration, years 0.47
DAS28, units 0.03
Lipid profile
TC, mg/dL <0.001
Tg, mg/dL 0.002
HDL-c, mg/dL <0.001
LDL-c, mg/dL 0.75
VLDL-c, mg/dL 0.17
ox-LDL, mg/dL <0.001
AIP, TC/HDL-c <0.001
Serological profile
ESR, mm/h 0.52
RF, IU/mL 0.61
CRP, mg/L <0.001
TNF , pg/mL <0.001
IL-6, pg/mL <0.001
Anti-CCP, U/mL 0.004
Flow  cytometry
CD36, MFI <0.001
DMARDs
Methotrexate, (%)36 (94.7)29 (100)0.14
Time of use, years 0.06
Chloroquine, (%)21 (55.3)15 (51.7)1.00
Sulfasalazine, (%)9 (23.7)4 (13.8)0.52
Azathioprine, (%)6 (15.8)4 (13.8)1.00
Corticosteroids, (%)3 (7.9)1 (3.5)0.45

RA: rheumatoid arthritis; cIMT: carotid intima-media thickness; DAS28: disease activity score; TC: total cholesterol; Tg: triglycerides; HDL-c: high density lipoprotein cholesterol; LDL-c: low density lipoprotein cholesterol; VLDL-c: very low density lipoprotein cholesterol; AIP: atherogenic index of plasma; ESR: erythrocyte sedimentation rate; RF: rheumatoid factor; CRP: C-reactive protein; TNF : tumor necrosis factor alpha; IL: interleukin; anti-CCP: anticyclic citrullinated peptides; MFI: mean fluorescence intensity; DMARDs: disease-modifying antirheumatic drugs.
Qualitative variables are expressed as frequencies (%); quantitative variables are expressed as means standard deviations (SD). Comparisons between proportions were computed using Chi-square or Fisher exact test. Comparisons between medians were computed with unpaired Student’s -test.